# HIV, Buprenorphine, and the Criminal Justice System

> **NCT01550341** · NA · COMPLETED · sponsor: **Yale University** · enrollment: 50 (actual)

## Conditions studied

- Human Immunodeficiency Virus
- Acquired Immunodeficiency Syndrome
- Opiate Addiction
- Drug Dependence

## Interventions

- **DRUG:** Buprenorphine/naloxone
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT01550341
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02-23
- **Primary completion:** 2015-11-30
- **Final completion:** 2016-11-30
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2020-05-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01550341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01550341, "HIV, Buprenorphine, and the Criminal Justice System". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT01550341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*